Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Raised Guidance Propel Optimism

Sales Growth: 12.7% year-over-year increase in Q1 2026.Total Sales: $1.65 billion in Q1 2026.TAVR Sales: $1.2 billion, 11% increase over the prior year.TMTT Sa